ImmunityBio, Inc. recently announced compelling new data from its ongoing QUILT 3.032 study. As of November 2024, 100 patients with Bacillus Calmette-Guérin (BCG)-unresponsive non-muscle invasive bladder cancer with carcinoma in situ (NMIBC CIS) have been treated... READ →
Precision Vaccinations
/ November 20th, 2024Eliminating fake vaccine news with pharmacist, nurse, and physician review.
For more articles, try our search.